Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1978 1
1984 1
1985 3
1986 4
1987 5
1988 3
1989 7
1990 2
1991 4
1992 5
1993 3
1994 2
1995 1
1996 1
1997 1
2000 1
2001 1
2012 1
2013 1
2014 2
2015 1
2020 1
2021 5
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: balabanova s. Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6. Lancet. 2021. PMID: 33838757 Free PMC article. Clinical Trial.
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: balabanova s. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Marson AG, et al. Among authors: balabanova s. Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750. Health Technol Assess. 2021. PMID: 34931602 Free article. Clinical Trial.
Drugs in ancient populations.
Parsche F, Balabanova S, Pirsig W. Parsche F, et al. Among authors: balabanova s. Lancet. 1993 Feb 20;341(8843):503. doi: 10.1016/0140-6736(93)90267-k. Lancet. 1993. PMID: 8094532 No abstract available.
First identification of drugs in Egyptian mummies.
Balabanova S, Parsche F, Pirsig W. Balabanova S, et al. Naturwissenschaften. 1992 Aug;79(8):358. doi: 10.1007/BF01140178. Naturwissenschaften. 1992. PMID: 1522918 No abstract available.
The neuroendocrine phenotype of gastric myofibroblasts and its loss with cancer progression.
Balabanova S, Holmberg C, Steele I, Ebrahimi B, Rainbow L, Burdyga T, McCaig C, Tiszlavicz L, Lertkowit N, Giger OT, Oliver S, Prior I, Dimaline R, Simpson D, Beynon R, Hegyi P, Wang TC, Dockray GJ, Varro A. Balabanova S, et al. Carcinogenesis. 2014 Aug;35(8):1798-806. doi: 10.1093/carcin/bgu086. Epub 2014 Apr 7. Carcinogenesis. 2014. PMID: 24710625 Free PMC article.
Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol.
Setiabudi W, Hungerford D, Subramaniam K, Vaselli NM, Shaw VE, Wilton M, Vivancos R, Aston S, Platt G, Moitt T, Jones AP, Gabbay M, Buchan I, Carrol ED, Iturriza-Gomara M, Solomon T, Greenhalf W, Naisbitt DJ, Adams ER, Cunliffe NA, Turtle L, French N; COVID-LIV Study Group. Setiabudi W, et al. BMJ Open. 2021 Mar 17;11(3):e048317. doi: 10.1136/bmjopen-2020-048317. BMJ Open. 2021. PMID: 33737446 Free PMC article.
Release of TGFβig-h3 by gastric myofibroblasts slows tumor growth and is decreased with cancer progression.
Holmberg C, Quante M, Steele I, Kumar JD, Balabanova S, Duval C, Czepan M, Rakonczay Z Jr, Tiszlavicz L, Nemeth I, Lazar G, Simonka Z, Jenkins R, Hegyi P, Wang TC, Dockray GJ, Varro A. Holmberg C, et al. Among authors: balabanova s. Carcinogenesis. 2012 Aug;33(8):1553-62. doi: 10.1093/carcin/bgs180. Epub 2012 May 18. Carcinogenesis. 2012. PMID: 22610072 Free PMC article.
Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).
Balabanova S, Taylor C, Sills G, Burnside G, Plumpton C, Smith PEM, Appleton R, Leach JP, Johnson M, Baker G, Pirmohamed M, Hughes DA, Williamson PR, Tudur-Smith C, Marson AG. Balabanova S, et al. BMJ Open. 2020 Aug 26;10(8):e040635. doi: 10.1136/bmjopen-2020-040635. BMJ Open. 2020. PMID: 32847927 Free PMC article.
59 results